Experience and quality you can trust.
With over 20 years experience as a Preclinical CRO, CBI has tissue cross-reactivity capabilities suitable for your unique research needs.
- Three phases:
- 1: Initial Characterization and Optimization
- 2: Preliminary TCR Screening
- 3: Full Cross-Reactivity Study (GLP)
- Tissue bank of various species including transgenic/knockout models, diseased tissue and tumors; frozen and fixed tissues for human tissue cross-reactivity studies
- Digital photomicroscopy, digital image analysis and histomorphometry
- GLP and non-GLP studies
- Expertise in immunohistochemistry, histology and immunopathology
- Study-specific protocols prepared to reflect your exact requirements
- Tissue evaluation by experienced ACVP board-certified veterinary pathologist
Our full service in vivo facility also offers:
- Full range of tissues
- On-site histopathology
- Immunohistochemistry
- In-house board-certified pathologist
- Efficient, quality reporting
- Archiving
Extensive experience with
- Small molecules
- Biologics
- Immunotherapy
- Stem cells
- Devices and implants
- Gene therapy
Standards of excellence
- GLP equipped
- AAALAC accredited
- USDA, FDA and OLAW compliant
Fill out the form below to learn more about our tissue cross-reactivity capabilities